ABSTRACT
We report the case of a 69-year-old man with bacterial meningitis who presented with ataxie optique in the peripheral part of the left visual field in both hands. A detailed neurological examination with contrast-enhanced brain MRI in the early stage of the clinical course identified a small subdural abscess and pialitis in the right parietal area. A favorable outcome was obtained with antibiotic therapy alone. In a case with higher brain dysfunction of unknown cause in the clinical course of bacterial meningitis, a detailed neurological examination may be helpful to identify the causative site. (Received September 25, 2023; Accepted October 31, 2023; Published March 1, 2024).
Subject(s)
Brain Abscess , Brain Diseases , Empyema, Subdural , Meningitis, Bacterial , Male , Humans , Aged , Abscess/complications , Abscess/diagnosis , Abscess/microbiology , Empyema, Subdural/complications , Empyema, Subdural/drug therapy , Empyema, Subdural/microbiology , Meningitis, Bacterial/diagnosis , Meningitis, Bacterial/drug therapy , Meningitis, Bacterial/complications , Brain Diseases/complications , Disease ProgressionABSTRACT
Central nervous system (CNS) involvement by actinomycosis is rare, seen in 2%-3% cases. It mostly spreads to CNS by haematogenous route from a distant primary site such as oral cavity, lung, abdomen or pelvis. Direct CNS extension can also occur. It mostly presents as brain abscess, meningoencephalitis, actinomycetoma, subdural empyema and epidural abscess. We report one case of extensive actinomycosis having intra and extraparenchymal CNS, spinal canal, retropharyngeal and mediastinal involvement. Due to such widespread extension and involvement of vital areas, complete surgical debulking was not possible. In addition to therapeutic resistance to conventional antibiotics, repetitive negative cultures posed significant difficulty in the case management.
Subject(s)
Actinomycosis , Brain Abscess , Empyema, Subdural , Epidural Abscess , Meningoencephalitis , Actinomycosis/diagnostic imaging , Actinomycosis/drug therapy , Brain Abscess/diagnostic imaging , Brain Abscess/drug therapy , Brain Abscess/surgery , Empyema, Subdural/diagnostic imaging , Empyema, Subdural/drug therapy , HumansABSTRACT
PURPOSE: The management of post-surgical subdural empyema and subdural abscess is not standardised. The objective was to analyse the efficacy and safety of oral sequential therapy (OST). METHODS: Retrospective observational study in a tertiary hospital in Vigo (Spain). We included adult patients with subdural abscess or epidural empyema with microbiological isolation. Clinical and demographic variables, isolated microorganisms and treatment regimens were included, as well as mortality and adverse effects during the follow-up period. RESULTS: Thirty patients were reviewed, two died due to causes other than infection. Six-month recurrence rate was 2/28 and all other patients (26/28) had clinical cure at the end of the treatment. The commonest isolated microorganisms were Gram-positive, especially Staphylococcus aureus. The most widely used oral antibiotic was trimethoprim-sulfamethoxazole (80%). No side effects related to oral treatment were observed. CONCLUSION: After adequate source control, OST can be a safe practice in the management of post-surgical epidural abscess and subdural empyema.
Subject(s)
Empyema, Subdural , Epidural Abscess , Staphylococcal Infections , Adult , Anti-Bacterial Agents/therapeutic use , Empyema, Subdural/drug therapy , Empyema, Subdural/surgery , Epidural Abscess/complications , Epidural Abscess/drug therapy , Epidural Abscess/surgery , Humans , Staphylococcal Infections/complications , Staphylococcal Infections/drug therapy , Staphylococcal Infections/surgery , Trimethoprim, Sulfamethoxazole Drug CombinationABSTRACT
BACKGROUND: Subdural empyema is a neurosurgical emergency requiring prompt diagnosis and treatment. There is a debate between the benefits and risks of starting early antibiotics prior to surgical drainage as this is purported to reduce the rate of microbiological diagnosis. Here, we describe our experience of treating this potentially life-threatening condition, advocating for the early commencement of antibiotics and importance of source control in its treatment. METHODS: Retrospective review of a prospectively collected electronic departmental database included all patients who were admitted to our unit with a diagnosis of subdural empyema over an 11-year period (2008-2018). Basic demographic data were collected. Further data pertaining to mode of presentation, surgical approach, causative organism, post-operative antibiotic regime, anti-seizure medications, length of hospital stay, further surgery, and neurological outcomes were extracted. RESULTS: Thirty-six children underwent 44 operations for subdural empyema at our institution during the study period. Median age was 11.0 (range 0.2-15.8); 47.2% (17/36) were female. Over time, there was decreasing use of burr holes and increasing use of craniectomy as the index surgery. Using a combination of extended culture and polymerase chain reaction, a microbiological diagnosis was achieved in all 36 cases; the commonest causative microorganism was of the Streptococcus anginosus group of bacteria. Seven patients underwent repeat surgery, and 4 patients underwent a concurrent ENT procedure. No risk factors were significant in predicting the likelihood of re-operation (location of subdural empyema, age, index surgery type, inflammatory markers, concurrent ENT procedure, and microorganism) although it was notable that none of the patients undergoing a concurrent ENT procedure underwent repeat surgery (p = 0.29). Median length of stay was 12 days (range 3-74), and there were no inpatient or procedure-related mortalities. Clinical outcomes were good with 94.4% (34/36) categorized as modified Rankin Scale 0-3 at discharge and there were 2 cranioplasty-related complications. CONCLUSIONS: We observed an evolution of practice from limited surgical approaches towards more extensive index surgery over the study period. Given that a microorganism was isolated in all cases using a comprehensive approach, initiation of antibiotic therapy should not be delayed on presentation. Concurrent ENT surgery may be an important factor in providing aggressive source control thereby reducing the need for repeat surgery.
Subject(s)
Empyema, Subdural , Anti-Bacterial Agents/therapeutic use , Child , Craniotomy , Empyema, Subdural/drug therapy , Empyema, Subdural/surgery , Female , Humans , Reoperation , Retrospective StudiesABSTRACT
Subdural empyema (SDE) is a rare condition which can appear secondary to meningitis in childhood, especially in infants. This study was planned to evaluate and compare clinical and laboratory features, treatment, and outcome of children with SDE to those with acute bacterial meningitis (ABM) without SDE. The electronic medical files of 266 patients diagnosed with ABM between January 2009 and December 2019 were evaluated. Patients' demographic and clinical features, laboratory results, cranial imaging findings, treatment, and outcomes were recorded. SDE was identified in 10 patients, 3.7% of all diagnosed with meningitis. The etiology of SDE was identified in eight (80%). The most common responsible pathogen was Streptococcus pneumoniae. Cranial imaging was performed between the 2nd and 13th days of admission, and the most common reason of performing cranial imaging was persistence of fever. Two patients were healed with 4-6 weeks of antibiotic treatment without surgery, eight (80%) needed surgical intervention.Conclusion: The clinical signs and symptoms of SDE may be subtle. If the fever persists or focal neurological findings are seen during the treatment of bacterial meningitis, SDE should be suspected. Furthermore, patients with ABM who are determined to have a protein-to-glucose ratio in the cerebrospinal fluid above 4.65 should be carefully monitored for SDE development. What is known: ⢠Subdural empyema may develop subsequently to meningitis, especially in the infant age group in whom very little is known in terms of disease characteristics. ⢠Delay in diagnosis and treatment can cause long-term neurologic sequelae and mortality. What is new: ⢠Persistence or relapse of fever during the treatment of acute meningitis is an important warning sign for SDE even if there are no other symptoms. ⢠Children with subdural empyema secondary to bacterial meningitis have higher protein-to-glucose ratio in the CSF, and a threshold of Ë 4.65 was determined to demonstrate 100% sensitivity and 50.7% specificity.
Subject(s)
Empyema, Subdural , Meningitis, Bacterial , Anti-Bacterial Agents/therapeutic use , Child , Empyema, Subdural/diagnosis , Empyema, Subdural/drug therapy , Empyema, Subdural/etiology , Glucose , Humans , Infant , Meningitis, Bacterial/complications , Meningitis, Bacterial/diagnosis , Meningitis, Bacterial/drug therapyABSTRACT
BACKGROUND: We report a case of subdural empyema in a homeless patient caused by Bartonella quintana. B. quintana is a facultative intracellular bacteria for which bacterial growth is fastidious. The molecular biology approach has been a real help in establishing the diagnosis. CASE REPORT: A 59-years old homeless patient, with a history of chronic alcohol abuse, was brought to the emergency department with a massive subdural empyema. Extensive microbiological evaluation didn't reveal any pathogen in the pus collected before antibiotic treatment. B. quintana was detected in the pus from the empyema using a 16S rRNA-based PCR. Histology of intraoperative samples was consistent with the diagnosis and a serological assay was positive. The patient responded well to a treatment that included craniectomy with drainage of the loculated pus, total removal of the infected capsule and a combination of antibiotics. CONCLUSION: This unique case of B. quintana-related empyema illustrates the risk of secondary infection of subdural hematoma with B. quintana since such infections have recently reemerged, predominantly among the homeless populations. Patients with subdural empyema in at-risk populations should be systematically evaluated for B. quintana with an appropriate diagnostic approach involving molecular biology.
Subject(s)
Bartonella quintana/genetics , Empyema, Subdural/diagnosis , Ill-Housed Persons , Trench Fever/diagnosis , Alcoholism/complications , Anti-Bacterial Agents/therapeutic use , Bartonella quintana/immunology , Craniotomy , Drainage , Empyema, Subdural/drug therapy , Empyema, Subdural/microbiology , Empyema, Subdural/surgery , Humans , Male , Middle Aged , Polymerase Chain Reaction , RNA, Ribosomal, 16S/genetics , Risk Factors , Treatment Outcome , Trench Fever/drug therapy , Trench Fever/microbiology , Trench Fever/surgeryABSTRACT
Clinical worsening or new manifestation of cryptococcal disease following initiation of anti-retroviral therapy (ART) in an HIV patient is a hallmark of cryptococcal immune reconstitution inflammatory syndrome (C-IRIS). However, it can be difficult to distinguish IRIS from worsening or new infection. Here, we present a case of severe C-IRIS involving multiple cerebellar, spinal, and intradural abscesses and spinal arachnoiditis 7 months after ART initiation in an AIDS patient with uncertain prior ART compliance. He had multiple prior episodes of cryptococcal meningitis with complications necessitating ventriculoperitoneal shunt placement and was on suppressive fluconazole when he developed worsening brain manifestations. He received empiric anti-cryptococcal re-induction without improvement. All cerebrospinal fluid cultures remained sterile, with negative Cryptococcus PCR testing, and his condition continued to worsen prior to corticosteroid initiation. Ultimately, C-IRIS was diagnosed by brain biopsy. This case demonstrates an extreme in severity of C-IRIS and in the timeline of presentation after ART initiation.
Subject(s)
Acquired Immunodeficiency Syndrome/drug therapy , Anti-Retroviral Agents/therapeutic use , Antifungal Agents/therapeutic use , Brain Abscess/diagnostic imaging , Empyema, Subdural/diagnostic imaging , Immune Reconstitution Inflammatory Syndrome/diagnostic imaging , Meningitis, Cryptococcal/drug therapy , Amphotericin B/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Arachnoid/pathology , Arachnoiditis/congenital , Arachnoiditis/diagnostic imaging , Arachnoiditis/drug therapy , Biopsy , Brain/pathology , Brain Abscess/drug therapy , Brain Edema/diagnostic imaging , Cerebellar Diseases/diagnostic imaging , Cerebellar Diseases/drug therapy , Empyema, Subdural/drug therapy , Fluconazole/therapeutic use , Flucytosine/therapeutic use , HIV Infections/drug therapy , Humans , Immune Reconstitution Inflammatory Syndrome/drug therapy , Magnetic Resonance Imaging , Male , Middle Aged , Prednisone/therapeutic use , RecurrenceABSTRACT
Intracranial subdural empyema is a rare clinical entity with incidence estimates of 0.1 per 100,000 people. The condition is most often the sequela of a primary infection elsewhere and carries a high morbidity and mortality. The authors present the case of a 22-year-old active duty soldier on mission on the southern border of the United States. The patient had been complaining of headaches that became progressively worse over 2 weeks and presented to a civilian hospital where he was diagnosed with intracranial abscess versus sinus thrombosis on radiographic imaging. The patient was promptly transferred to a military tertiary care center where further workup including pivotal imaging confirmed subdural empyema and right transverse sinus thrombosis. Given the rapid patient deterioration associated with subdural empyema, the emergent intravenous antibiotics, neurosurgical consultation, and subsequent collection evacuation performed are likely to credit for saving this soldier's life. This case highlighted an atypical and time-sensitive etiology for a common complaint in the active duty population, which underscores the requirement for evacuation to higher roles of care in those soldiers with a similar diagnosis.
Subject(s)
Empyema, Subdural , Military Personnel , Anti-Bacterial Agents/therapeutic use , Empyema, Subdural/diagnosis , Empyema, Subdural/drug therapy , Empyema, Subdural/etiology , Humans , Male , Young AdultABSTRACT
BACKGROUND: Invasive meningococcal disease (IMD) presenting with meningitis causes significant mortality and morbidity. Suppurative complications of serogroup B meningococcal sepsis are rare and necessitate urgent multidisciplinary management to mitigate long-term morbidity or mortality. CASE PRESENTATION: We present a rare case of invasive meningococcal disease in a 28-month old boy complicated by multiple abscess formation within a pre-existing antenatal left middle cerebral artery territory infarct. Past history was also notable for cerebral palsy with right hemiplegia, global developmental delay and West syndrome (infantile spasms). Two craniotomies were performed to achieve source control and prolonged antimicrobial therapy was necessary. The patient was successfully discharged following extensive multidisciplinary rehabilitation. CONCLUSIONS: Longstanding areas of encephalomalacia in the left MCA distribution may have facilitated the development of multiple meningococcal serogroup B abscess cavities in the posterior left frontal, left parietal and left temporal lobes following an initial period of cerebritis and meningitis. A combination of chronic cerebral hypoperfusion and some degree of pre-existing necrosis in these areas, may also have facilitated growth of Neisseria meningitidis, leading ultimately to extensive cerebral abscess formation following haematogenous seeding during meningococcemia. In this case report we review similar cases of cerebral abscess or subdural empyema complicating serogroup B meningococcal meningitis.
Subject(s)
Brain Abscess/microbiology , Meningitis, Meningococcal/complications , Neisseria meningitidis, Serogroup B/genetics , Anti-Bacterial Agents/therapeutic use , Brain Abscess/drug therapy , Brain Abscess/surgery , Cerebral Infarction/complications , Cerebral Palsy/complications , Child, Preschool , Craniotomy , Empyema, Subdural/drug therapy , Empyema, Subdural/microbiology , Follow-Up Studies , Hemiplegia/complications , Humans , Male , Meningitis, Meningococcal/prevention & control , Polymerase Chain Reaction , Sepsis/drug therapy , Sepsis/microbiology , Treatment Outcome , VaccinationABSTRACT
OBJECTIVES: To present the guidelines of the French Society of Otolaryngology-Head and Neck Surgery concerning the use of non-steroidal anti-inflammatory drugs (NSAIDs) in pediatric ENT infections. METHODS: Based on a critical analysis of the medical literature up to November 2016, a multidisciplinary workgroup of 11 practitioners wrote clinical practice guidelines. Levels of evidence were classified according to the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) system: GRADE A, B, C or "expert opinion". The first version of the text was reworked by the workgroup following comments by the 22 members of the reading group. RESULTS: The main recommendations are: NSAIDs are indicated at analgesic doses (e.g. 20-30 mg/kg/day for ibuprofen) in combination with paracetamol (acetaminophen) in uncomplicated pediatric ENT infections (acute otitis media, tonsillitis, upper respiratory infections, and maxillary sinusitis) if: o pain is of medium intensity (visual analogue scale (VAS) score 3-5 or "Evaluation Enfant Douleur" (EVENDOL) child pain score 4-7) and insufficiently relieved by first-line paracetamol (residual VAS≥3 or EVENDOL≥4); o pain is moderate to intense (VAS 5-7 or EVENDOL 7-10). When combined, paracetamol and ibuprofen are ideally taken simultaneously every 6h. It is recommended: (1) o not to prescribe NSAIDs in severe or complicated pediatric ENT infections; (2) o to suspend NSAIDs treatment in case of unusual clinical presentation of the infection (duration or symptoms); (3) o not to prescribe NSAIDs for more than 72h.
Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Pediatrics , Acetaminophen/therapeutic use , Analgesics, Non-Narcotic/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Contraindications, Drug , Dose-Response Relationship, Drug , Drug Interactions , Drug Therapy, Combination , Empyema, Subdural/drug therapy , France , Humans , Lymphadenitis/drug therapy , Meningitis/drug therapy , Otitis/drug therapy , Pain Measurement , Respiratory Tract Infections/drug therapy , Societies, MedicalABSTRACT
Necrotising otitis externa (NOE) is an infection originating in the soft tissues of the external auditory canal (EAC) spreading to the surrounding bone and rarely causing intracranial complications. It is usually caused by Pseudomonas aeruginosa and has historically occurred in elderly patients with diabetes or immunodeficiency. EAC foreign body is a risk factor for otitis externa but has not been described in NOE. A healthy 31-year-old man presented with new-onset seizures and worsening left-sided otalgia and otorrhoea. Brain imaging revealed left temporal subdural abscesses superior to the petrous bone. A retained cotton bud was identified in the left EAC, along with osseocartilaginous junction and mastoid granulation tissue. The foreign body was removed; a cortical mastoidectomy performed and intravenous antibiotic administered. At 10 weeks, the patient remained well, with no neurological deficit and no residual ear symptoms, and CT demonstrated complete resolution of the intracranial abscesses.
Subject(s)
Ear Canal/microbiology , Empyema, Subdural/etiology , Otitis Externa/microbiology , Adult , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Ear Canal/pathology , Ear Diseases/complications , Earache/diagnosis , Empyema, Subdural/diagnostic imaging , Empyema, Subdural/drug therapy , Foreign Bodies , Granulation Tissue , Humans , Male , Mastoid/pathology , Mastoid/surgery , Mastoidectomy/methods , Necrosis/pathology , Otitis Externa/diagnosis , Otitis Externa/drug therapy , Otitis Externa/pathology , Seizures/diagnosis , Tomography, X-Ray Computed/methods , Treatment OutcomeSubject(s)
Brain Diseases , Empyema, Subdural , Anti-Bacterial Agents/therapeutic use , Brain Diseases/diagnostic imaging , Brain Diseases/drug therapy , Brain Diseases/surgery , Empyema, Subdural/diagnostic imaging , Empyema, Subdural/drug therapy , Empyema, Subdural/surgery , Humans , Magnetic Resonance Imaging , Neurosurgical ProceduresABSTRACT
BACKGROUND: Central nervous system (CNS) infections caused by Actinomyces spp. including brain abscess, actinomycoma, subdural empyema and epidural abscess are well described, however reports of Actinomyces-associated meningitis are scarcely reported. CASE REPORT: We present the case of a 43-year-old Hungarian male patient with poor socioeconomic status who developed acute bacterial meningitis caused by Actinomyces turicensis originating from the left side mastoiditis. The bacterial cultures of both cerebrospinal fluid (CSF) and purulent discharge collected during the mastoid surgery showed slow growing Gram-positive rods that were identified by automated systems (API, VITEK) as A. turicensis The bacterial identification was confirmed by 16S rRNA PCR and subsequent nucleic acid sequencing. No bacterial growth was detected in blood culture bottles after 5 days of incubation. Hence, multiple antibacterial treatments and surgical intervention the patient passed away. CONCLUSIONS: Anaerobes are rarely involved in CNS infections therefore anaerobic culture of CSF samples is routinely not performed. However, anaerobic bacteria should be considered as potential pathogens when certain risk factors are present, such as paranasal sinusitis, mastoiditis in patients with poor socioeconomic condition. To the best of our knowledge, our case report is the first description of A. turicensis meningitis that has been diagnosed as consequence of purulent mastoiditis.
Subject(s)
Actinomyces/isolation & purification , Actinomycosis/complications , Brain Abscess/microbiology , Empyema, Subdural/microbiology , Mastoiditis/complications , Meningitis, Bacterial/microbiology , Actinomyces/genetics , Adult , Anti-Bacterial Agents/therapeutic use , Brain Abscess/cerebrospinal fluid , Brain Abscess/drug therapy , Empyema, Subdural/cerebrospinal fluid , Empyema, Subdural/drug therapy , Fatal Outcome , Humans , Male , Mastoiditis/cerebrospinal fluid , Mastoiditis/drug therapy , Mastoiditis/microbiology , Meningitis, Bacterial/cerebrospinal fluid , Meningitis, Bacterial/drug therapy , Polymerase Chain Reaction , Poverty , RNA, Ribosomal, 16S/genetics , Social ClassABSTRACT
A 60-year-old male patient with a large infected cranial apex lesion was admitted with lethargy and mental status changes. The patient underwent evaluation with imaging studies, a skin biopsy, cultures with microscopy and a diagnostic burr hole. MRI and positron emission tomography/CT scan revealed a squamous cell carcinoma with ingrowth in the midline of the brain and subdural empyema infected with Streptococcus anginosus and Staphylococcus aureusHigh dose intravenous antibiotic treatment was initiated and the patient subsequently underwent a surgical resection of the carcinoma with a 1 cm margin of surrounding skin and skull. The defect was reconstructed using a titanium plate and a free microvascular lattisimus dorsi muscle flap then covered with a split skin graft.The patient received 37 radiation therapy sessions (66 GY) as adjuvant therapy.Intensive neurorehabilitation slowly improved an initial paraparesis. The 7-month follow-up revealed a satisfactory cosmetic result and residual gait impairment secondary to central nervous system invasion.
Subject(s)
Carcinoma, Squamous Cell/therapy , Dura Mater/surgery , Empyema, Subdural/therapy , Head and Neck Neoplasms/therapy , Plastic Surgery Procedures/methods , Scalp , Skin Neoplasms/therapy , Biopsy , Carcinoma, Squamous Cell/complications , Carcinoma, Squamous Cell/diagnostic imaging , Carcinoma, Squamous Cell/pathology , Empyema, Subdural/drug therapy , Empyema, Subdural/etiology , Empyema, Subdural/microbiology , Head and Neck Neoplasms/complications , Head and Neck Neoplasms/diagnostic imaging , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Positron-Emission Tomography , Radiation-Sensitizing Agents/therapeutic use , Scalp/diagnostic imaging , Scalp/pathology , Scalp/surgery , Skin Neoplasms/complications , Skin Neoplasms/diagnostic imaging , Skin Neoplasms/pathology , Skin Transplantation , Skull/diagnostic imaging , Skull/surgery , Surgical FlapsABSTRACT
Intracranial complications of paranasal sinusitis have become rare due to the use of antibiotics nowadays. However, several cases have been reported due the ability of paranasal sinusitis to cause serious complications. Once the infection spreads over the cranial structure, it could infect the orbits, underlying bones, meninges, adjacent veins, and brain. Subdural empyema is a rare but potentially life-threatening complication following paranasal sinusitis and should be considered as a neurological emergency. The location where subdural empyema may appear is a challenge in diagnosis and treatment. We report the case of a 17-year-old boy who presented in a state of somnolence due to interhemispheric and infratentorial subdural empyema with preseptal cellulitis secondary to pansinusitis. Early diagnosis and aggressive antibiotic treatment combined with neurosurgical operation were mandatorily implemented. The case was managed using a multidisciplinary approach including the ENT, eye, and nutrition departments. The boy achieved clinical improvement, with impairment of eye movement as the only persistent symptom before discharge. Daily supervision at the primary health care center with continuous antibiotic treatment was recommended to the patient. Pertinent literature with controversies in the management of subdural empyema will be briefly discussed in this case report.
Subject(s)
Cellulitis , Empyema, Subdural/diagnosis , Sinusitis/complications , Adolescent , Anti-Bacterial Agents/therapeutic use , Cellulitis/etiology , Empyema, Subdural/diagnostic imaging , Empyema, Subdural/drug therapy , Empyema, Subdural/etiology , Humans , Male , Tomography, X-Ray ComputedSubject(s)
Empyema, Subdural/microbiology , Meningitis, Meningococcal/microbiology , Neisseria meningitidis/pathogenicity , Polyradiculopathy/microbiology , Anti-Bacterial Agents/therapeutic use , Ceftriaxone/therapeutic use , Dexamethasone/therapeutic use , Empyema, Subdural/complications , Empyema, Subdural/diagnostic imaging , Empyema, Subdural/drug therapy , Humans , Magnetic Resonance Imaging , Male , Meningitis, Meningococcal/complications , Meningitis, Meningococcal/diagnostic imaging , Meningitis, Meningococcal/drug therapy , Neisseria meningitidis/drug effects , Neisseria meningitidis/physiology , Penicillin G/therapeutic use , Polyradiculopathy/diagnostic imaging , Polyradiculopathy/etiology , Polyradiculopathy/surgery , Serogroup , Vancomycin/therapeutic use , Young AdultABSTRACT
BACKGROUND: There have been various reports concerning Helicobacter cinaedi infections. However, few reports have examined central nervous system infections. CASE PRESENTATION: A 52-year-old man was transferred from the local hospital because of a persistent headache and suspected intracranial subdural empyema. Neurosurgical drainage was performed via burr holes. Gram staining and results from abscess cultures were negative. The blood culture yielded H. cinaedi. He was given an antibiotic regimen consisting of 2 g of ceftriaxone twice a day, but the size of the abscess was not reduced in size at all after 3 weeks of treatment. Neurosurgical drainage was performed again, and the antimicrobial regimen was switched to 2 g of meropenem 3 times a day. The size of the abscess was reduced after 2 weeks of the second drainage and antimicrobial drug change to meropenem. After 4 weeks treatment with meropenem, the patient was discharged, and his symptoms had completely resolved. CONCLUSIONS: H. cinaedi infection should be considered in the differential diagnosis of subdural empyema cases for which Gram staining and abscess culture results are negative. Meropenem can be a first-line drug of choice or an effective alternative treatment for H. cinaedi central nervous system infections.
Subject(s)
Bacteremia/drug therapy , Empyema, Subdural/drug therapy , Helicobacter Infections/drug therapy , Helicobacter Infections/microbiology , Abscess/drug therapy , Anti-Bacterial Agents/therapeutic use , Anti-Infective Agents/therapeutic use , Bacteremia/microbiology , Ceftriaxone/therapeutic use , Drainage , Empyema, Subdural/microbiology , Helicobacter/genetics , Helicobacter/pathogenicity , Humans , Male , Meropenem , Middle Aged , Thienamycins/therapeutic use , Treatment OutcomeABSTRACT
OBJECTIVE: To describe a case of successful medical management of subdural intracranial empyema and multifocal pneumonia in a domestic longhaired cat. CASE SUMMARY: A 7-year-and-8-month-old male neutered domestic longhair cat presented with tachypnea, respiratory compromise, vestibular ataxia, obtundation, left-sided head tilt, and multiple cranial nerve deficits. Neuroanatomical localization was multifocal with central vestibular involvement. Magnetic resonance imaging of the head indicated diffuse subdural empyema, mainly affecting the middle cranial fossa and the right cerebrum. Analysis of cerebrospinal fluid revealed degenerate neutrophils with a mixed population of intracellular bacilli. Computed tomography (CT) of the thorax was suggestive for multifocal pneumonia. Aggressive medical management with IV fluids, oxygen supplementation, mannitol boluses, dexamethasone, and broad-spectrum antimicrobials was initiated. The cat demonstrated gradual improvement within 24 hours following initiation of treatment. General physical and neurological examinations, 9 weeks after initiating treatment, did not reveal any abnormalities. A CT examination performed at this time revealed resolution of the cat's pulmonary lesions. The cat was still free of clinical signs, 9 months after treatment was started. NEW OR UNIQUE INFORMATION PROVIDED: Subdural empyema is infrequently reported in cats and has high mortality rates even following surgical treatment. To the authors' knowledge, this is the first reported case of successful medical management of a cat with subdural empyema and suggests that aggressive medical management should be attempted in cats that are not considered surgical candidates.
Subject(s)
Anti-Bacterial Agents/therapeutic use , Cat Diseases/drug therapy , Dexamethasone/therapeutic use , Empyema, Subdural/veterinary , Pneumonia/veterinary , Animals , Anti-Infective Agents/therapeutic use , Cats , Empyema, Subdural/drug therapy , Fluid Therapy , Humans , Male , Pneumonia/drug therapyABSTRACT
BACKGROUND CONTEXT: Spinal subdural abscess (SSA) is a rare occurrence for which the management typically involves open surgical removal and washout. PURPOSE: This case report aims to review the literature and discuss the management of patients with SSA. STUDY DESIGN: We present a case of a 33-year-old female who presented with a spinal epidural abscess and concurrent SSA. She presented in the context of intravenous (IV) drug use, back pain, and generalized lower extremity weakness. METHODS: The literature was reviewed with a focus on modern treatment options for SSA. Our patient was managed with IV antibiotics, and separate laminectomies and washouts for both lesions. RESULTS: The patient recovered well with return of neurologic function and normalization of infection markers. The review of the literature resulted in a management flowchart that will help direct treatment of SSA. CONCLUSIONS: The literature suggests that in a patient with a definitive diagnosis of SSA, limited surgical management and IV antibiotics are the mainstay of treatment in a patient with a decline in neurologic function. There may be a role for expectant management in the absence of diagnostic imaging or the neurologically stable patient.